Valuation (76%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 26.18 | 27.09 |
PEG Ratio (TTM) | -0.58 | 42.79 |
P/S Ratio (TTM) | 0.61 | 7.24 |
P/B Ratio (TTM) | 1.92 | 6.12 |
P/FCF Ratio (TTM) | 7.51 | 22.61 |
Price to 5YR AVG Earnings Ratio | 11.45 | 69.29 |
Price to 5YR AVG FCF Ratio | 4.56 | 36.11 |
Profitability (30%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.01% | 6.18% |
ROE (TTM) | 7.02% | 19.94% |
Net Profit Margin (TTM) | 2.33% | 6.98% |
ROIC 5YR AVG | 16.80% | 11.92% |
Growth (32%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -33.53% | -2,847.42% | -1,717.98% |
Revenue | -1.23% | 12.32% | 3.01% |
Net Income | -34.55% | -2,784.31% | -1,683.19% |
Cash Flow | 33.73% | 83.96% | 42.60% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.40 | 1.56 |
Quick Ratio (TTM) | 0.82 | 1.13 |
D/E Ratio (TTM) | 1.40 | 0.94 |
Interest Coverage (TTM) | 1.81 | 14.00 |
Piotroski F-Score | 5 | 7 |
Altman Z-Score | 2.01 | 3.58 |
LTL to 5YR AVG FCF | 3.33 | 6.67 |
Shares Outstanding Growth 5YR AVG | -5.34% | 3.63% |